Based on the Narayana Hrudayalaya Ltd. stock forecast from 2 analysts, the average analyst target price for Narayana Hrudayalaya Ltd. is INR 1,392.50 over the next 12 months. Narayana Hrudayalaya Ltd.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Narayana Hrudayalaya Ltd. is Bullish , which is based on 9 positive signals and 2 negative signals. At the last closing, Narayana Hrudayalaya Ltd.’s stock price was INR 1,266.55. Narayana Hrudayalaya Ltd.’s stock price has changed by +2.26% over the past week, +2.76% over the past month and +66.34% over the last year.
No recent analyst target price found for Narayana Hrudayalaya Ltd.
No recent average analyst rating found for Narayana Hrudayalaya Ltd.
Company Overview Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Limited provides medical and healthcare services in India and internationally. The company acquires, owns, and operates hospitals, clinics, health centers, and nursing homes. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology services. The company was incorporated in 2000 and is headquartered in Bengaluru, India. Read Less
Narayana Hrudayalaya Limited provides medical and healthcare services in India and internationally. The company acquires, owns, and operates hospitals, clinics, health centers, and nursing homes. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery...Read More
Frequently Asked Questions About Narayana Hrudayalaya Ltd. (NH:NSE) Stock
Based on ratings from 2 analysts Narayana Hrudayalaya Ltd.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 2 buy, sell and hold ratings.
NH:NSE stock's dividend yield is 0.20%.
Our analysis grades NH:NSE stock's dividend yield at F. This means that NH:NSE stock's dividend yield is above 22% of the stocks in the Medical Care Facilities sector in the NSE exchange.
Based on this NH:NSE may be a poor dividend stock for its sector.
Based on targets from 2 analysts, the average taret price for NH:NSE is INR 1,392.50 over the next 12 months. The maximum analyst target price is INR 1435 while the minimum anlayst target price is INR 1350.
NH:NSE stock's Price/Earning ratio is 33.80.
Our analysis grades NH:NSE stock's Price / Earning ratio at C+. This means that NH:NSE stock's Price/Earning ratio is above 21% of the stocks in the Medical Care Facilities sector in the NSE exchange.
Based on this NH:NSE may be undervalued for its sector.
The last closing price of NH:NSE's stock was INR 1,266.55.
The most recent market capitalization for NH:NSE is INR 262.36B.
Based on targets from 2 analysts, the average taret price for NH:NSE is projected at INR 1,392.50 over the next 12 months.
This means that NH:NSE's stock price may go up by +9.94% over the next 12 months.
We can't find any ETFs which contains Narayana Hrudayalaya Ltd.'s stock.
As per our most recent records Narayana Hrudayalaya Ltd. has 11,923 Employees.
Narayana Hrudayalaya Ltd.'s registered address is 261/A, Bommasandra Industrial Area, Bengaluru, India, 560099.
You can get more information about it from Narayana Hrudayalaya Ltd.'s website at https://www.narayanahealth.org.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for NH:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
